NO961226L - Blandinger for forebyggelse og behandling av viralinduserte tumorer - Google Patents

Blandinger for forebyggelse og behandling av viralinduserte tumorer

Info

Publication number
NO961226L
NO961226L NO961226A NO961226A NO961226L NO 961226 L NO961226 L NO 961226L NO 961226 A NO961226 A NO 961226A NO 961226 A NO961226 A NO 961226A NO 961226 L NO961226 L NO 961226L
Authority
NO
Norway
Prior art keywords
viral
prevention
compounds
treatment
induced tumors
Prior art date
Application number
NO961226A
Other languages
English (en)
Other versions
NO961226D0 (no
Inventor
Ernest W Boyer
Robert L Charles
Original Assignee
Solvay Enzymes Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Enzymes Inc filed Critical Solvay Enzymes Inc
Publication of NO961226D0 publication Critical patent/NO961226D0/no
Publication of NO961226L publication Critical patent/NO961226L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/913—Aspergillus
    • Y10S435/917—Aspergillus niger

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO961226A 1993-09-27 1996-03-26 Blandinger for forebyggelse og behandling av viralinduserte tumorer NO961226L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/126,660 US5500359A (en) 1993-09-27 1993-09-27 Method for producing a therapeautic composition for papillomavirus-induced tumors with aspergillus niger
PCT/IB1994/000303 WO1995008998A1 (en) 1993-09-27 1994-09-16 Compositions for the prevention and treatment of viral-induced tumors

Publications (2)

Publication Number Publication Date
NO961226D0 NO961226D0 (no) 1996-03-26
NO961226L true NO961226L (no) 1996-05-23

Family

ID=22426064

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961226A NO961226L (no) 1993-09-27 1996-03-26 Blandinger for forebyggelse og behandling av viralinduserte tumorer

Country Status (11)

Country Link
US (4) US5500359A (no)
EP (1) EP0725646A1 (no)
JP (1) JPH09503206A (no)
KR (1) KR960704561A (no)
CN (1) CN1087941C (no)
AU (1) AU699133B2 (no)
BR (1) BR9407660A (no)
CA (1) CA2172261A1 (no)
FI (1) FI961380A0 (no)
NO (1) NO961226L (no)
WO (1) WO1995008998A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945116A (en) * 1996-11-05 1999-08-31 Haque, Inc. Compositions for the prevention and treatment of warts, skin blemishes and other viral-induced tumors
US6406706B1 (en) 1996-11-05 2002-06-18 Haque, Inc. Use of α- and β-santalols major constituents of sandal wood oil, in the treatment of warts, skin blemishes and other viral-induced tumors
US6132756A (en) * 1996-11-05 2000-10-17 Haque, Inc. Use of sandalwood oil for the prevention and treatment of warts, skin blemishes and other viral-induced tumors
US6230013B1 (en) 1997-11-26 2001-05-08 Telefonaktiebolaget Lm Ericsson (Publ) Diversity handling moveover for CDMA mobile telecommunications
CA2276219A1 (en) * 1999-06-25 2000-12-25 Board Of Trustees Of The University Of Arkansas Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction
US20050175634A1 (en) * 1999-06-25 2005-08-11 The Board Of Trustees Of The University Of Arkansas Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction
US6350451B1 (en) * 1999-06-25 2002-02-26 The Board Of Trustees Of The University Of Arkansas Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction
US20070031786A1 (en) * 2002-02-25 2007-02-08 Heil Donald J Dental handpiece
US7780992B2 (en) * 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
US7311928B2 (en) * 2003-12-09 2007-12-25 Briant Burke Topical compositions containing tea tree oil for treatment of viral lesions
WO2005121802A1 (de) * 2004-06-09 2005-12-22 Heinz Voigt Proteindifferenzierung
JP2010510310A (ja) 2006-11-22 2010-04-02 スタンダード バイオロジックス インコーポレイテッド コウジカビプロテアーゼを使用する処置の方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3230153A (en) * 1963-06-26 1966-01-18 Birger H Olson Process for the production of regulin by aspergillus restrictus and resulting product
US3819832A (en) * 1970-07-20 1974-06-25 N Joshi Antiviral agent fwh-775 and method of production
JPS5231030B2 (no) * 1973-05-12 1977-08-12
JPS577420A (en) * 1980-06-18 1982-01-14 Yamasa Shoyu Co Ltd Antitumor agent
JPS5795913A (en) * 1980-12-08 1982-06-15 Yamasa Shoyu Co Ltd Antitumor agent
DE3343331A1 (de) * 1983-11-28 1985-06-05 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von indanyl-derivaten und deren verwendung
BR8902936A (pt) * 1989-05-30 1990-12-04 Nunes E Duran Pesquisa Comerci Anidrido polimerico de fosfolinoleato de magnesio e anonio proteico,com propriedades anti-virais-neoplasticas e imunoestimulantes e processo de obtencao do mesmo
JPH0645547B2 (ja) * 1989-06-05 1994-06-15 雪印乳業株式会社 免疫増強剤
US5316345A (en) * 1992-06-26 1994-05-31 Madison Roberta E Single panel communication card and its color method

Also Published As

Publication number Publication date
US5662903A (en) 1997-09-02
AU7706294A (en) 1995-04-18
KR960704561A (ko) 1996-10-09
EP0725646A1 (en) 1996-08-14
NO961226D0 (no) 1996-03-26
US5662902A (en) 1997-09-02
CN1087941C (zh) 2002-07-24
CN1134671A (zh) 1996-10-30
JPH09503206A (ja) 1997-03-31
WO1995008998A1 (en) 1995-04-06
US5500359A (en) 1996-03-19
CA2172261A1 (en) 1995-04-06
FI961380A (fi) 1996-03-26
BR9407660A (pt) 1997-01-28
FI961380A0 (fi) 1996-03-26
US5562900A (en) 1996-10-08
AU699133B2 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
NO971015D0 (no) Forbindelser og metoder for behandling av cancer
FI941826A (fi) Menetelmät ja koostumukset elimen hypofunktion ennaltaehkäisemiseksi ja/tai terapeuttiseksi hoitamiseksi
NO990225D0 (no) Medikamenter for behandling av hyperfosfatemi
NO971900D0 (no) Blandinger og behandling av multippel sklerose
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
GB2269164B (en) Treatment of polyvinylchloride
AU6946594A (en) Methods for the treatment and prevention of diarrhea
NO961226L (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
NO983512D0 (no) Midler for behandling og forhindring av AIDS
ZA954984B (en) Compositions and methods for the treatment of tumors
NO952820D0 (no) Behandling av avfallspetroleum
IL101410A0 (en) Formulation for the treatment of cancer
ZA944772B (en) Treatment of fluids
NO932850L (no) Fremgangsmaate for fremstilling av staal
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO982562D0 (no) Sammensetning for behandling av smerte
EP0733365A3 (en) Use of benzoquinolin-3-one for the treatment and prevention of prostate cancer
EP0552289A4 (en) Prevention or treatment of sunburn using the s(+) isomer of ketoprofen
GB9317943D0 (en) Treatment of laminitis
IL128095A0 (en) Formulation for the treatment and/or prophylaxis of dementia
GB9402886D0 (en) The treatment of gaseous substances
EP0502470A3 (en) Compounds for the treatment of inflammation and allergy
NO932160D0 (no) Fremgangsmaate for deteksjon av cathepsin g og alfa-1-antichymotrypsin komplekser
KR940002718U (ko) 치질예방 및 치료기